2,820 reports of this reaction
1.8% of all ESTRADIOL reports
#11 most reported adverse reaction
ARTHRALGIA is the #11 most commonly reported adverse reaction for ESTRADIOL, manufactured by Allergan, Inc.. There are 2,820 FDA adverse event reports linking ESTRADIOL to ARTHRALGIA. This represents approximately 1.8% of all 159,657 adverse event reports for this drug.
Patients taking ESTRADIOL who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for ESTRADIOL, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for ESTRADIOL:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 2,820 FDA reports for ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 1.8% of all adverse event reports for ESTRADIOL, making it a notable side effect.
If you experience arthralgia while taking ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.